Striatal volume differences between non-human and human primates - PubMed (original) (raw)
Comparative Study
Striatal volume differences between non-human and human primates
Dali Yin et al. J Neurosci Methods. 2009.
Abstract
Convection-enhanced delivery (CED) has recently entered the clinic and represents a promising new delivery option for targeted gene therapy in Parkinson's disease (PD). The prime stereotactic target for the majority of recent gene therapy clinical trials has been the human putamen. The stereotactic delivery of therapeutic agents into putamen (or other subcortical structures) via CED remains problematic due to the difficulty in knowing what volume of therapeutic agent to deliver. Preclinical studies in non-human primates (NHP) offer a way to model treatment strategies prior to clinical trials. Understanding more accurately the volumetric differences in striatum, especially putamen, between NHP and humans is essential in predicting convective volume parameters in human clinical trials. In this study, magnetic resonance images (MRI) were obtained for volumetric measurements of striatum (putamen and caudate nucleus) and whole brain from 11 PD patients, 13 aged healthy human subjects, as well as 8 parkinsonian and 30 normal NHP. The human brain is 13-18 times larger than the monkey brain. However, this ratio is significantly smaller for striatum (5.7-6.5), caudate nucleus (4.6-6.6) and putamen (4.4-6.6). Size and species of the monkeys used for this comparative study are responsible for differences in ratios for each structure between monkeys and humans. This volumetric ratio may have important implications in the design of clinical therapies for PD and Huntington's disease and should be considered when local therapies such as gene transfer, local protein administration or cellular replacement are translated based on NHP research.
Figures
Figure 1
Volume of right and left putamen, caudate nucleus and striatum in normal humans, in PD patients, in parkinsonian and normal Rhesus, and in normal Cynomolgus monkeys
Figure 2
MR images of putamen (green outline) in representative normal (A) and parkinsonian (B) Rhesus monkey
Figure 3. Comparison of representative MR images of putamen (outlined in green) from human PD patient (A) and normal Rhesus monkey (B)
The monkey striatum has been enlarged relative to the human to facilitate comparison.
Figure 4. Volume of putamen, caudate nucleus and striatum in normal human vs normal Rhesus monkeys, normal human vs Cynomolgus monkeys, and Parkinsonian patient vs Parkinsonian Rhesus monkey
H, human; R, Rhesus; C, Cynomolgus; PP, parkinsonian patient; PR, parkinsonian Rhesus. **, p < 0.0001. Ratiometric differences are indicated above each data set.
Figure 5. Comparison of representative MR images of from human (A) and Rhesus monkey (B) (putamen outlined in white)
The images are scaled to illustrate the 5-fold greater striatal volume of the human striatum compared to that of the Rhesus monkey.
Similar articles
- Parkinson׳s disease-related modulation of functional connectivity associated with the striatum in the resting state in a nonhuman primate model.
Li J, Luo C, Chen Y, Chen Q, Huang R, Sun J, Gong Q, Wu X, Qi Z, Liang Z, Li L, Li H, Li P, Wang W, Shang HF. Li J, et al. Brain Res. 2014 Mar 25;1555:10-9. doi: 10.1016/j.brainres.2014.01.054. Epub 2014 Feb 13. Brain Res. 2014. PMID: 24530271 - The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P, Lévesque M, Parent A. Huot P, et al. Brain. 2007 Jan;130(Pt 1):222-32. doi: 10.1093/brain/awl332. Epub 2006 Dec 2. Brain. 2007. PMID: 17142832 - MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.
Miletich RS, Bankiewicz KS, Quarantelli M, Plunkett RJ, Frank J, Kopin IJ, Di Chiro G. Miletich RS, et al. Ann Neurol. 1994 Jun;35(6):689-97. doi: 10.1002/ana.410350609. Ann Neurol. 1994. PMID: 8210225 - Neurosurgical convection-enhanced delivery of treatments for Parkinson's disease.
Lam MF, Thomas MG, Lind CR. Lam MF, et al. J Clin Neurosci. 2011 Sep;18(9):1163-7. doi: 10.1016/j.jocn.2011.01.012. Epub 2011 Jul 13. J Clin Neurosci. 2011. PMID: 21745745 Review. - The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future.
Fox SH, Brotchie JM. Fox SH, et al. Prog Brain Res. 2010;184:133-57. doi: 10.1016/S0079-6123(10)84007-5. Prog Brain Res. 2010. PMID: 20887873 Review.
Cited by
- Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF.
Kells AP, Eberling J, Su X, Pivirotto P, Bringas J, Hadaczek P, Narrow WC, Bowers WJ, Federoff HJ, Forsayeth J, Bankiewicz KS. Kells AP, et al. J Neurosci. 2010 Jul 14;30(28):9567-77. doi: 10.1523/JNEUROSCI.0942-10.2010. J Neurosci. 2010. PMID: 20631185 Free PMC article. - An Ecological and Neural Argument for Developing Pursuit-Based Cognitive Enrichment for Sea Lions in Human Care.
Cook PF, Reichmuth C. Cook PF, et al. Animals (Basel). 2024 Mar 4;14(5):797. doi: 10.3390/ani14050797. Animals (Basel). 2024. PMID: 38473182 Free PMC article. - Treatment of Parkinson's disease with biologics that penetrate the blood-brain barrier via receptor-mediated transport.
Pardridge WM. Pardridge WM. Front Aging Neurosci. 2023 Nov 13;15:1276376. doi: 10.3389/fnagi.2023.1276376. eCollection 2023. Front Aging Neurosci. 2023. PMID: 38035276 Free PMC article. Review. - Rules ventral prefrontal cortical axons use to reach their targets: implications for diffusion tensor imaging tractography and deep brain stimulation for psychiatric illness.
Lehman JF, Greenberg BD, McIntyre CC, Rasmussen SA, Haber SN. Lehman JF, et al. J Neurosci. 2011 Jul 13;31(28):10392-402. doi: 10.1523/JNEUROSCI.0595-11.2011. J Neurosci. 2011. PMID: 21753016 Free PMC article. - Fetal dopamine receptor characteristics assessed in utero.
Bartlett RM, Dejesus OT, Barnhart TE, Nickles RJ, Christian BT, Graner JL, Holden JE. Bartlett RM, et al. J Cereb Blood Flow Metab. 2010 Aug;30(8):1437-40. doi: 10.1038/jcbfm.2010.77. Epub 2010 Jun 9. J Cereb Blood Flow Metab. 2010. PMID: 20531464 Free PMC article.
References
- Aminoff MJ. Parkinson’s disease. Neurologic clinics. 2001;19:119–28. vi. - PubMed
- Bankiewicz KS, Eberling JL, Kohutnicka M, Jagust W, Pivirotto P, Bringas J, Cunningham J, Budinger TF, Harvey-White J. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Experimental neurology. 2000;164:2–14. - PubMed
- Bankiewicz KS, Oldfield EH, Chiueh CC, Doppman JL, Jacobowitz DM, Kopin IJ. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Life sciences. 1986;39:7–16. - PubMed
- Berardelli A, Noth J, Thompson PD, Bollen EL, Curra A, Deuschl G, van Dijk JG, Topper R, Schwarz M, Roos RA. Pathophysiology of chorea and bradykinesia in Huntington’s disease. Mov Disord. 1999;14:398–403. - PubMed
- Berheimer H, Birkmayer W, Hornykiewics O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington- clinical, morphological and neurochemical correlations. Journal of Neurological Sciences. 1973;20:415–55. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 NS050156-03/NS/NINDS NIH HHS/United States
- R01 NS050156/NS/NINDS NIH HHS/United States
- U54 NS045309/NS/NINDS NIH HHS/United States
- U54NS045309/NS/NINDS NIH HHS/United States
- U54 NS045309-010002/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical